CPI - DEL CARIBE
Manufacturer adverse-event records for CPI - DEL CARIBE come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.
FDA MAUDE device safety record · 2003–2023 · heavy-book · elevated Death-code · injury-heavy
Volume signature
CPI - DEL CARIBE sits in the heavy MAUDE book
CPI - DEL CARIBE accounts for 64,619 FDA MAUDE reports (#51 of 443, heavy-book tercile). Death-coded event_type share is 0.95% (elevated); Injury share 73.9% (injury-heavy).
What the volume reading shows for CPI - DEL CARIBE
The standout signal for CPI - DEL CARIBE is filing volume: 64,619 adverse-event reports in FDA MAUDE (#51 of 443, heavy-book). Death-coded event_type share sits at 0.95% (elevated).
As a heavy-book manufacturer, portfolio size and reporting obligations inflate absolute counts - pair CPI - DEL CARIBE with device-family pages before treating company totals as a safety verdict. Event_type Death and Injury are one code per report; Patient Outcomes below use a separate FDA population.
Reports span 12 device types, led in this extract by Injury at 47,768 (73.9% of event_type total). Peak single-year volume reaches 8,494 reports across 17 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.
Event Types
Patient Outcomes
FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.
Devices (12)
Yearly Trend
Read our methodology - how this data is sourced, computed, and verified.